Table 2

Epidemiological, clinical and radiological features in Paediatric Series of 2019 novel coronavirus disease (COVID‐19)

Qiu et al 14 Lu et al 6 CDC COVID-19 Response Team15
Number of patients361712572
Place of recruitmentZhejiang Province, ChinaWuhan, Hubei Province, ChinaUSA
Median age (range)3.5 years (0–15 years)6.7 years (0–15 years)11 years (0–17 years)
Female (%)13 (36.1)67 (39.2)1,082/2,490 (43.5)
Epidemiological features, n (%)
Household contact with confirmed or suspected cases32 (89)154 (90.1)168/184 (91.3)
Contact with other confirmed or suspected cases02 (1.2)
Travel exposure12 (33)All from Wuhan16/184 (8.7)
Unidentified source of infection015 (8.8)
Clinical classifications, n (%)
Asymptomatic infection10 (27.7)27 (15.8)NA
Upper respiratory infection7 (19.4)33 (19.3)NA
Pneumonia19 (52.8)111 (64.9)NA
Intensive care03 (1.8)15/745 (estimated range 0.58–2.0)
Signs and symptoms, n (%)
Fever13 (36.1)71 (41.5)163/291 (56)
Cough7 (19.4)83 (48.5)158/291 (54)
Pharyngeal congestion or sore throat2 (5.6)79 (46.2)71/291 (24)
Rhinorrhoea013 (7.6)21/291 (7.2)
Diarrhoea2 (5.6)15 (8.8)37/291 (13)
Vomiting2 (5.6)11 (6.4)31/291 (11)
Laboratory findings, n (%)
Leucopenia7 (19.4)45 (26.3)NA
Lymphopenia11 (30.5)6 (3.5)NA
Elevated procalcitonin6 (16.7)105 (64.0)NA
Elevated C reactive protein1 (2.8)33 (19.7)NA
Elevated D-dimer3 (8.3)21 (14.1)NA
Chest CT, n (%)
Ground-glass opacity19 (52.8)56 (32.7)NA
  • CDC, Centers for Disease Control and Prevention; NA, not available.